In this presentation a quantitative study, prepared by CSFD Working Group on the EU Action Plan, will be presented. The research aims to contribute to the monitoring and evaluation of the current Action Plan (2017-20) by assessing perspectives and views of European NGOs on how relevant actions included in the Action Plan are implemented in their own countries.
It is clear that in some countries access to services and the quality of service is much higher than in others. European Commission should strengthen the drug coordination system and initiate dialogue with those states where access to services is low. EU Member states should, in the first place, fill the gaps in funding and political support for services that were perceived to have very low accessibility, improve the quality of services by implementing minimum quality standards, create formal mechanisms to involve civil society in drug policy decision making in a meaningful way in local and national level and assess the needs of specific vulnerable populations and, where appropriate, provide funding for specific services to reach out these groups.